# A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD

> **NCT02934932** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 15 (actual)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Brexpiprazole

## Key facts

- **NCT ID:** NCT02934932
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-25
- **Primary completion:** 2018-04-30
- **Final completion:** 2018-04-30
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Terminated due to slow enrollment.
- **Last updated:** 2019-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934932, "A Pilot Dose-Response Biomarker Study of Brexpiprazole Treatment in PTSD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02934932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*